A review on the molecular mechanisms, the therapeutic treatment including the potential of herbs and natural products, and target prediction of obesity-associated colorectal cancer

Pharmacol Res. 2022 Jan:175:106031. doi: 10.1016/j.phrs.2021.106031. Epub 2021 Dec 9.

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. Obesity has been proven to be closely related to colorectal carcinogenesis. This review summarized the potential underlying mechanisms linking obesity to CRC in different aspects, including energy metabolism, inflammation, activities of adipokines and hormones. Furthermore, the potential therapeutic targets of obesity-associated CRC were predicted using network-based target analysis, with total predicted pathways not only containing previously reported pathways, but also putative signaling pathways pending for investigation. In addition, the current conventional therapeutic treatment options, plus the potential use of herbs and natural products in the management of obesity-associated CRC were also discussed. Taken together, the aim of this review article is to provide strong theoretical basis for future drug development, particularly herbs and natural products, in obesity-associated CRC.

Keywords: Colorectal cancer; Conventional medicines; Herbs; Natural products; Network pharmacology; Obesity; Obesity-associated colorectal cancer; Target prediction.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / etiology
  • Humans
  • Obesity / complications
  • Obesity / drug therapy*
  • Phytotherapy*

Substances

  • Biological Products